Search Results

Moderna to develop booster shot after South African strain decreased its coronavirus vaccine’s antibody levels

February 10, 2021 -

Laboratory analysis showed that the Moderna jab had six times less antibodies that block the virus from human cell receptors when tested against the South African B1351 strain. That amount of antibodies can still provide protection, albeit on a shorter period. Moderna is now working on a booster shot for the South African strain, which is going into pre-clinical trials as of writing.

The pharmaceutical firm said its vaccine worked just as well against the B117 variant ...

FDA identifies dozens of inaccurate coronavirus antibody tests

June 01, 2020 -

A total of 27 vendors will no longer be allowed to sell their antibody tests because they haven’t been shown to work. Yesterday, the FDA published a list of the makers whose tests will no longer be marketed or distributed; it’s not known whether they will be facing additional penalties. Many of them appear to be from Chinese companies.

In tests carried out by ABC News and the Mayo Clinic, half of the antibody tests examined were found to be unreliable, with one even saying ...

Food allergies or toxic buildup? Study finds that despite a recent increase in reported food allergies, no corresponding change in antibody levels have been found

March 14, 2019 -

Food allergies in children have grown by 50 percent since 1990. Almost five percent of all children in the U.S. are diagnosed with food allergy, mostly from milk, eggs, shellfish, and peanuts. Self-reported food allergy rates have risen, including the number of emergency room visits and hospitalizations related to it. The study, published in the April 2016 issue of Journal of Allergy and Clinical Immunology, suggests that the increase of food allergy reports may be due to the ...

AstraZeneca’s experimental “antibody cocktail” fails to prevent coronavirus symptoms

June 21, 2021 -

The trial, named "Storm Chaser," was on Phase III. It involved 1,121 adult volunteers from the United States and the United Kingdom. The vast majority of the volunteers did not have COVID-19 symptoms at the start of the trial. But they were exposed to the coronavirus soon after the trial started.

AstraZeneca claimed the goal of the trial was to figure out whether the long-acting antibody cocktail it developed could protect people who had recently been in contact with coronavirus-positive ...

AstraZeneca begins advanced trials for COVID-19 antibody medication

October 26, 2020 -

The two initial trials for the antibody-drug will assess its ability to prevent infections for as much as a year in some patients. The trials will also explore the drug's use as a preemptive treatment for patients exposed to SARS-CoV-2. Long-acting antibodies such as the ones used in AstraZeneca’s drug mimic the ones found in the human body; these have the potential to halt the effects of COVID-19 in infected patients. AZD7442 could also be used to complement a vaccine against ...

FDA panel unanimously supports new RSV antibody drug for infants

June 14, 2023 -

All 21 members of the FDA's Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted in favor of the monoclonal antibody nirsevimab on June 8. The committee agreed that the benefits of nirsevimab exceed the dangers in preventing RSV infections for newborns and infants in their initial RSV season. With the AMDAC's decision, nirsevimab is closer to receiving final regulatory approval.

In a separate 19-2 vote, the AMDAC supported the monoclonal antibody's use in children ...

FDA criticized for restricting the use of COVID antibody treatments

January 27, 2022 -

The drugs, bamlanivimab and etesevimab (which are administered together) and REGEN-COV (casirivimab and imdevimab) were limited in their use, allegedly because they are unlikely to work against the omicron variant.

Florida Governor Ron DeSantis, who opened treatment centers to distribute the drugs, slammed the FDA's decision, saying that they had acted without a shred of clinical data to support their decision.

"There are real-world implications to Biden's medical ...

Eli Lilly monoclonal antibody drug trial paused over safety concerns

October 20, 2020 -

According to company spokeswoman Molly McCully, an independent data and safety monitoring board (DSMB) had recommended pausing enrollment in the U.S. government-sponsored trials. Lilly, however, did not say what caused the panel to recommend the pause.

“Safety is of the utmost importance to Lilly,” said McCully. “Lilly is supportive of the decision by the independent DSMB to cautiously ensure the safety of the patients participating in this study,” she added, referring ...

This Ayurvedic herb can regulate immune function and stimulate antibody production

April 20, 2021 -

Besides skin conditions, herbal medicines containing black cutch extracts are used to treat a wide variety of diseases, including asthma, bronchitis, colic, diarrhea, ulcers, anemia and stomatitis (mouth inflammation). Recent studies have also found that the bark, heartwood and sap of this useful plant have many pharmaceutical properties, such as anthelmintic, antihyperglycemic, antipyretic and anti-inflammatory activities.

In a recent study, researchers at Mahatma Gandhi ...

Doubts raised on effectiveness of coronavirus antibody testing in the UK

July 15, 2020 - antibody levels associated with milder and asymptomatic cases.

Based on their findings, the researchers said that the U.K. government’s antibody program should only be carried out for population-wide research purposes as scientists can adjust for accuracy limitations when looking at large datasets. The antibody tests should not, however, be used to inform individual decision-making.

Eleanor Riley, professor of immunology and infectious disease at Edinburgh University, ...

FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment

November 12, 2020 -

The FDA extended the emergency approval to the experimental therapy known as “bamlanivimab.” It may be given to people 12 years old and older who have mild to moderate cases of the coronavirus and have not visited the emergency room or have been admitted to a hospital. Bamlanivimab is a one-time treatment that is administered through an IV.

In a statement, FDA Commissioner Stephen M. Hahn gave his support for the approval of bamlanivimab.Bamlanivimab is known ...

Medical scientists cautiously describe 100% CURE for cancer using new monoclonal antibody treatment

June 09, 2022 -

The results of the small trial are already being hailed as "remarkable" and "unprecedented" because all 18 participants are now cancer-free, thanks to receiving dostarlimab every three weeks for six months.

One of the patients is now two years out of the trial and still cancer-free, which Dr. Luis A. Diaz Jr., the study's author, told The New York Times "is the first time this has happened in the history of cancer."

Fellow co-author Dr. Andrea Cercek, an oncologist ...

Covid “negative” patients are overwhelming hospitals, exactly as predicted with Antibody Dependent Enhancement

November 10, 2021 -

According to the talking-heads, these people do not have the Wuhan coronavirus (Covid-19) because many of them are "fully vaccinated," so the whole thing is a "mystery," they claim.

Since the jabs are "safe and effective," there is no explanation for this latest crisis. It must just be a coincidence, right?

"ERs are now swamped with seriously ill patients – but many don't even have covid," reported Michigan Radio.

NPR also relayed the story, pretending ...

Serotonin levels

a long time ago - Natural.News

Natural Health News & Self-Reliance

GlaxoSmithKline faces hundreds of lawsuits after pushing birth defect-causing drug on pregnant women

Nearly 200 lawsuits have been filed this year alone against GlaxoSmithKline (GSK) for birth defects caused by a chemotherapy drug prescribed to expecting mothers suffering from morning sickness. Made by GSK, Zofran’s only approved use was to prevent nausea and vomiting brought about by chemotherapy and radiation; however, ...

Another 14 states have been cut off from monoclonal antibody treatments, compliments of the Biden regime

April 05, 2022 -

The latest reports show that another 14 states are now prohibited from receiving shipments of sotrovimab, which is manufactured by GlaxoSmithKline (GSK) and Vir Biotechnology.

A March 30 announcement from the Department of Health and Human Services (HHS) indicated that the total number of states that are no longer receiving sotrovimab has reached 22.

The latest 14 states to get the axe include Alaska, Arizona, California, Hawaii, Idaho, Illinois, Indiana, Michigan, ...

VAXXED TO DEATH: Alarming study confirms vaxxers will face catastrophic Antibody Dependent Enhancement injuries and deaths

August 17, 2021 -

According to OurWorldInData.org, 31.7% of the world population has been vaccinated with one or more covid vaccines. That's about 2.4 billion people.

In the United States, according to the CDC, 199 million people have been vaccinated with at least one dose.

Notably, all the 2.4 billion people who took this vaccine around the world have taken an unproven, deadly, experimental medical intervention that was intentionally formulated to contain spike protein biological ...

QUACKERY: After granting EUA to covid vaccines for antibody response, FDA now says antibodies are useless

June 15, 2021 -

After earlier declaring antibody tests to be a gold standard in identifying the presence of the Chinese Virus, Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health, is "reminding the public" that there are severe "limitations" when it comes to Wuhan Flu antibody or serology testing.

"Antibody tests can play an important role in identifying individuals who may have been exposed ...

Drug maker Eli Lilly strikes $375 million deal with US government for COVID-19 antibody treatment

November 02, 2020 -

Per the initial terms of the agreement, the company will deliver the bamlanivimab vials for two months after FDA approval. The deal also provides the option for the U.S. government to purchase up to an additional 650,000 vials through June 2021. However, the purchase of the succeeding doses will be subject to agreement from Eli Lilly, product availability and domestic medical demand.

If bamlanivimab is authorized for emergency use, the government has committed that ...

Vaccine science is built on LIES: Antibody measurements after vaccination do not equate to comprehensive, lifelong immunity

December 15, 2025 -

The relentless focus on antibody levels as the sole measure of protection is a scientific sleight of hand, one that ignores the breathtaking complexity of the human immune system while lining the pockets of an industry built on a myth. This obsession with a single, easily measured metric has diverted our understanding of true health and left us chasing boosters for viruses that outsmart our shots before the ink on the prescription is dry. It is time to pull back the ...

CDC advisers voted on an RSV antibody using incomplete and intentionally manipulated data hiding seizure and death risks

August 25, 2025 -

The vote passed 5 to 2, but the foundation of that decision is now crumbling under the weight of new revelations. Independent analyses by investigative journalists and researchers suggest that the safety data presented to ACIP was incomplete, selectively framed, and in some cases, outright misleading. At the heart of the controversy is a troubling question: How could a committee tasked with protecting public health make such a consequential decision without seeing the full picture?...